Prescription Drug Monitoring Programs-Lack of Effectiveness or a Call to Action?

Pain Medicine

Volumn 12, Issue 5, 2011, Pages 687-689

  Kerlikowske, Gil ^a   Jones, Christopher M ^b   Labelle, Regina M ^c   Condon, Timothy P ^a  

^a Office of National Drug Control Policy   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; DRUG ABUSE; DRUG MONITORING; DRUG OVERDOSE; EDITORIAL; HUMAN; MORTALITY; PHYSICIAN; PRESCRIPTION; UNITED STATES;

EID: 79955886788     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01108.x     Document Type: Editorial

References (13)

1. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: A ten year perspective. Pain Physician 2010;13:401-35.
2. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health. Vol. I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4586Findings).Rockville, MD: HHS Publication; 2010.
3. Centers for Disease Control and Prevention. Emergency department visits involving nonmedical use of selected prescription drugs-United States, 2004-2008. MMWR 2010;59(23):705-9.
4. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS). 1998-2008. National Admissions to Substance Abuse Treatment Services. DASIS Series: S-50, HHS Publication No. (SMA) 09-4471. Rockville, MD: HHS Publication; 2010.
5. Centers for Disease Control and Prevention. CDC's issue brief: Unintentional drug poisoning in the United States. Available at: (accessed February 2011).
6. U.S. General Accounting Office. Prescription Drugs: State Monitoring Programs Provide Useful Tool to Reduce Diversion. Washington, DC: U.S. General Accounting Office; 2002. Report No. GAO-02-634.
7. Simeone R, Holland L. An Evaluation of Prescription Drug Monitoring Programs. Washington, DC: U.S. Department of Justice, Office of Justice Programs; 2006.
8. Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med 2011. doi: 10.1111/j.1526-4637.2011.01062.x. [Epub ahead of print].
9. Alliance of States with Prescription Monitoring Programs. PMP Legislation and Operational Dates. Available at: (accessed March 2011).
10. Blumenschein K, Fink JL, Freeman PR, etal. Independent evaluation of the impact and effectiveness of the Kentucky All Schedule Prescription Electronic Reporting Program (KASPER). Available at: (accessed March 2011).
11. Alliance of States with Prescription Monitoring Programs. State profiles. Available at: (accessed March 2011).
12. Phillips DM. JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA 2000;284:428-9.
13. The Council of State Government. CSG to convene PDMP drafting team meeting. Available at: (accessed March 2011).